Three months after insurance companies stopped covering cannabis flowers, the consequences for the supply infrastructure are becoming concrete. One of Germany’s largest pharmacies specializing in medical cannabis has filed for insolvency.
📑 Inhaltsverzeichnis
Pharmacy Lux 99 in Hürth, North Rhine-Westphalia, filed for insolvency under self-administration on October 19, 2026, according to the industry portal apotheke-adhoc. Owner Tobias Loder attributed the move to a dramatic drop in revenue following the GKV Contribution Rate Stabilization Act, which removed medical cannabis flowers from insurance coverage at the end of July 2026.
According to the business, over 80 employees work in the cannabis sector. Operations are to be continued and restructured as part of the self-administration process. Loder also serves as board representative of the Association of Cannabis-Supplying Pharmacies.
What Self-Administration Means
Self-administration means that the existing management continues to run the business under the supervision of a court-appointed custodian, rather than being replaced by an insolvency administrator. The process is designed for restructuring and requires the court to expect no disadvantages for creditors. For patients, this initially means: the pharmacy remains open. However, this is not a guarantee of the outcome.
The Connection Is Direct Here
In this insolvency case, the cause is clear. A pharmacy that specialized in one area of care lost a substantial portion of its revenue when that coverage ended. Those focused on flowers covered by insurance have faced a market since late July where the same service is now only sought as a private service, at prices many patients cannot afford.
We’ve broken down what this means financially for patients based on cost per milligram of THC. Patient advocates in the Joint Federal Committee had previously called for protection of ongoing therapies, and the Working Group Cannabis as Medicine petitioned the committee. Whether old approvals remain valid is currently being decided differently by social courts.
Context
An insolvency is not proof of a thesis—it’s an individual case with a history. What’s remarkable here, however, is twofold. First, the owner himself cites the legislative change as the cause, and the timing is tight. Second, this affects not a marginal provider, but a business whose owner represents the association of supplying pharmacies publicly.
For the supply system, the question is less whether this one business survives, but how many specialized pharmacies remain. Specialization has been a quality marker in this field because it consolidates expertise in counseling, inventory management, and quality control. Now it is simultaneously a concentration risk.
Sources: Coverage by apotheke-adhoc from October 19, 2026; newsletter of the Cannabiswirtschaft industry association from October 21, 2026; original reporting. Information about the business based on company statements. Status: October 21, 2026.
Sollten Cannabisblüten weiterhin von der Kasse erstattet werden?
Branchen-Update
News, Analysen und Reportagen — mehrmals im Monat direkt in dein Postfach.
Folge uns
